Financial

Medicrea Reports Third Quarter 2017 Sales
Financial

Medicrea Reports Third Quarter 2017 Sales

October 12, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD™ ASI technology, publishes its sales for the 3rd quarter ended September 30, 2017. € millions 2016 2017 Change Q3 […]

OrthoPediatrics Corp. (Nasdaq: KIDS) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO
Financial

OrthoPediatrics Corp. (Nasdaq: KIDS) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO

ADVISORY, Oct. 13, 2017 (GLOBE NEWSWIRE) What: OrthoPediatrics Corp. (Nasdaq:KIDS), the only orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions, will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering […]

EOS imaging Reports 28% Sales Growth for the Third Quarter 2017
Financial

EOS imaging Reports 28% Sales Growth for the Third Quarter 2017

October 12, 2017 PARIS–(BUSINESS WIRE)–EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – SME), the pioneer of orthopaedic medical imaging, 2D/3D, today announced its (non-audited) consolidated sales for the third quarter ended September 30, 2017. The Company also announced the appointment of Eric Maulavé as Chief Operating Officer […]

Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call
Financial

Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call

October 12, 2017 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it is adjusting guidance for the third quarter of 2017 as a result of the impact of Hurricanes Irma and Harvey. CEO […]

Anika to Issue Third-Quarter 2017 Financial Results and Business Highlights on Wednesday, October 25
Financial

Anika to Issue Third-Quarter 2017 Financial Results and Business Highlights on Wednesday, October 25

October 11, 2017 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2017 financial results after the close of the market on Wednesday, October 25, 2017 and to hold a conference call the next day, Thursday, October 26, 2017, at 9:00 a.m. ET […]

Wright Medical Group N.V. to Host Third Quarter 2017 Earnings Conference Call
Financial

Wright Medical Group N.V. to Host Third Quarter 2017 Earnings Conference Call

AMSTERDAM, The Netherlands, Oct. 11, 2017 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ:WMGI) today announced that it will host a conference call on Wednesday, November 1, 2017, at 3:30 p.m. Central Time to discuss the company’s operating results for its third quarter ended September 24, 2017.  Operating results will be released at 3:00 p.m. Central Time that day. The […]

Implanet: 20% Increase in Revenue In Q3 2017
Financial

Implanet: 20% Increase in Revenue In Q3 2017

October 10, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces its sales for the third quarter and first nine months to September 30, 2017. Ludovic Lastennet, CEO of Implanet, says: […]

MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent
Financial

MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent

MARIETTA, Ga., Oct. 10, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today its preliminary revenue results for the third quarter of 2017. Third Quarter 2017 Revenue Highlights  […]

MiMedx Board of Directors Authorizes $10 Million Increase to the Company’s Share Repurchase Program
Financial

MiMedx Board of Directors Authorizes $10 Million Increase to the Company’s Share Repurchase Program

MARIETTA, Ga., Oct. 9, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today the decision of its Board of Directors to authorize a $10 million increase in the Company’s Share […]

Mazor Robotics Received 22 System Orders During Q3 2017; Expects to Report Record Quarterly Revenue
Financial Robotics

Mazor Robotics Received 22 System Orders During Q3 2017; Expects to Report Record Quarterly Revenue

October 09, 2017 CAESAREA, Israel–(BUSINESS WIRE)–Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical robotic systems, expects to report record revenue of approximately $17.2 million for the third quarter ended September 30, 2017. During the third quarter of 2017, the Company received […]

MiMedx Completes Divestiture Of Its Stability Biologics Subsidiary
Biologics Financial Top Stories

MiMedx Completes Divestiture Of Its Stability Biologics Subsidiary

MARIETTA, Ga., Oct. 2, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that it has completed the previously communicated divestiture of the Company’s subsidiary, Stability Biologics LLC […]

OrthoPediatrics Corp. Announces Launch of Initial Public Offering
Financial

OrthoPediatrics Corp. Announces Launch of Initial Public Offering

WARSAW, Ind., Oct. 02, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today the launch of the initial public offering of 4,000,000 shares of its common stock. OrthoPediatrics will grant the underwriters a 30-day […]